ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.

Examination of the structural basis for antiviral activity, oral pharmacokinetics, and hepatic metabolism among a series of symmetry-based inhibitors of the human immunodeficiency virus (HIV) protease led to the discovery of ABT-538, a promising experimental drug for the therapeutic intervention in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kempf, D J, Marsh, K C, Denissen, J F, McDonald, E, Vasavanonda, S, Flentge, C A, Green, B E, Fino, L, Park, C H, Kong, X P
Format: Artigo
Langue:Inglês
Publié: 1995
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC42242/
https://ncbi.nlm.nih.gov/pubmed/7708670
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires